Hajian K. Minimal annual incidence rate of esophageal carcinoma: adult population in Mazandaran province (1992–98), North of Iran. Journal of Research in Medical Sciences 2002;1(7):18–22.
Saidi F. The historical basis for the “Esophageal cancer belt of south central Asia”. Archives of Iranian Medicine 1999;1(2):26–7.
Meyets D, Schchat B, Lee H, et al. A serological and molecular survey for HTLV1 in high risk middle eastern group. Lancet 1990;336:1533–5.CrossRef
Farid Hosseini R. HTLV1 infection and associated diseases. Medical Journal of Mashad University of Medical Sciences 2002;76(45):129–40.
Dalgliesh AG. Viruses and cancer. Br Med Bull 1991;47:21–46.
Negri E, La vecchia C, Franceschi S, et al. Attributable risks for esophageal cancer in northern Italy. Eur J Cancer 1992;28A:1167–72.PubMedCrossRef
Ashraful H, Scott LM, Tsung-Teh W. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 2005;26(4):785–91.CrossRef
Farid Hosseini R, Etemadi MM, Baradaran H, Malek Nejad A, Amina H, Shahriari Z. Seroepidemiology of HTLV-1 in the city of Mashhad. Journal of Medical Council of Islamic Republic of Iran 1995;4(13):318–21.
Teich N. Taxonomy of retrovirus. In: Weoss R, Teich N, Varus H, et al, editors. RNA tumor viruses. Cold Spring Harbor, NY: Cold Springer Laboratory; 1985,. p. 1–16.
Kinoshita K, Amagasaki T, Ikeda S, et al. Preleukemic state of adult T-cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia lymphoma virus. Blood 1985;66:120–7.PubMed
Kwok RP, Laurence ME, Lundblad JR, et al. Control of cAMP-regulated enhancer by the viral transactivator tax through CREB and the a co-activator CMP. Nature 1996;380:642–6.PubMedCrossRef
Lenz Meier BA, Giebler HA, Nyborg JK, et al. Human T cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the promoter. Mol Cell Biol. 1998;18:721–31.
Pise-Masison CA, Choi KS, Radonovich M, et al. Inhibition of P53
transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol 1998;72:1165–70.PubMed
Mahboubi E, Kmet J, Cook PJ, et al. Esophageal cancer studies in the Caspian littoral of Iran. Br J Cancer 1973;28:197.PubMed
Alaeddini F, Holakuei K, Mahmoodi M, Siyasi F, Nadim AH. Esophageal cancer and type of food and beverage consumption. Archives of Iranian Medicine 2001;4(4):197–200.
Moradi A, De Villiers EM, Mokhtari Azad T, Mahmoudi M, Hazrati B, Ghaemi E, Nategh R. Detection of human Papillomavirus DNA by PCR in esophageal squamous cell carcinoma from Turkmen Sahra, north-east of Iran. Iran Biomed J 2002;1(6):19–23.
Wu M-Y, Wu X-Y, Zhuang C-x. Detection of HSV and EBV in esophageal carcinomas from a high-incidence area in Shantou China. Dis Esophagus 2005;18(1):46–50.PubMedCrossRef
Sedaghat Y, Elahi E, Raii M. EBV infection of esophageal cancer tissue as determined by PCR. Iran J Med Sci 1999;2–1(24):53–62.
Naroth H, Shibata J, Kawagouchi A, et al. Over expression and localization of cyclin D1 in RNA and antigen in esophageal cancer. Am J Pathol 1995;146:1161–4.
Mirhassani Moghaddam SJ, Daneshmand MA, Aghakhani A, Edrissian MO, Zali MR. P53 and Rb genes expression changes in esophageal squamous cell carcinoma in Iran. Journal of Research in Medical Sciences 2002;4(7):340–5.
Duvall JF, Kashanchi F. Transcriptional coactivator CBP facilitates transcription initiation and reinitiation of HTLV-1 and Cyclin D2 promoter. Iran Biomed J 1998;2(2):49–57.
Hollestein MC, Metralf RA, Walsk JA, et al. Frequent mutation of the P53
gene in human esophageal cancer. Proc Natl Acad Sci U S A 1990;87:9958–61.CrossRef